Gleason, Carey E.

Amyloid-β 11 C-PiB-PET imaging results from 2 randomized bapineuzumab phase 3 AD trials

Liu, E., Schmidt, M. E., Margolin, R., Sperling, R., Koeppe, R., Mason, N. S., Klunk, W. E., Mathis, C. A., Salloway, S., Fox, N. C., et al. (2015) · Neurology

Alzheimer's disease research and treatmentsDementia and Cognitive Impairment Research

Cited by 151

Alzheimer's disease biomarkers in Black and non-Hispanic White cohorts: a contextualized review of the evidence

Gleason, C. E., Zuelsdorff, M., Gooding, D. C., Kind, A. J. H., Johnson, A. L., James, T. T., Lambrou, N. H., Wyman, M. F., Ketchum, F. B., Gee, A., et al. (2022) · Alzheimer's & Dementia

Dementia and Cognitive Impairment ResearchAlzheimer's disease research and treatments

Cited by 104

Illness Representations in Older Adults with Mild Cognitive Impairment

Lin, F., Gleason, C. E., & Heidrich, S. M. (2012) · Research in Gerontological Nursing

Dementia and Cognitive Impairment ResearchAging and Gerontology Research

Cited by 26

Unstructured clinical documentation reflecting cognitive and behavioral dysfunction: toward an EHR-based phenotype for cognitive impairment

Gilmore-Bykovskyi, A. L., Block, L. M., Walljasper, L., Hill, N., Gleason, C., & Shah, M. N. (2018) · Journal of the American Medical Informatics Association

Machine Learning in HealthcareDementia and Cognitive Impairment Research

Cited by 21